Is Sarepta Therapeutics Making Money?
I think Sarepta (NASDAQ: SRPT) is a terrible stock because it loses money. For example, Sarepta reported a quarterly operating loss of -$137.07 million on 30 September 2020.
Continue Reading
Is Sarepta Therapeutics Making Money?